Lv1
80 积分 2023-08-28 加入
Pembrolizumab with chemoradiation as treatment for muscle-invasive bladder cancer: analysis of safety and efficacy of the PCR-MIB phase 2 clinical trial (ANZUP 1502)
2天前
已完结
AJCC第8版乳腺癌分期系统更新的解读
6个月前
已完结
Modified Simiaowan prevents and treats gouty arthritis via the Nrf2/NLRP3 inflammasome signaling pathway
7个月前
已完结
Targeting angiogenesis in oncology, ophthalmology and beyond
9个月前
已完结
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study
10个月前
已完结
Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
11个月前
已完结
Association between treatment duration and overall survival in early-stage HER2+ breast cancer patients receiving extended adjuvant therapy with neratinib in the ExteNET trial
11个月前
已关闭
139P HER2+/HR+ breast cancer patients at high risk of relapse derive benefit from extended adjuvant treatment with neratinib: An exploratory analysis from ExteNET study
11个月前
已完结
Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China
1年前
已关闭
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
1年前
已关闭
皖公网安备34019202002308
